Q32 Bio (QTTB) Return on Capital Employed (2018 - 2026)

Q32 Bio's Return on Capital Employed history runs 9 years deep, the most recent figure standing at 41.13% for Q1 2026.

• In Q1 2026, Return on Capital Employed rose 13039.0% year-over-year to 41.13%; the TTM figure through Mar 2026 stood at 41.13% (up 13039.0% YoY), while the FY2025 annual figure was 25.72%, up 14991.0% from the prior year.
• Return on Capital Employed was 41.13% for Q1 2026 at Q32 Bio, up from 34.9% in the prior quarter.
• In the past five years, Return on Capital Employed ranged from a high of 58.3% in Q3 2023 to a low of 89.65% in Q2 2025.
• Historically, Return on Capital Employed has averaged 29.83% across 5 years, with a median of 23.54% in 2022.
• The sharpest annual moves came in 2024 and 2026: Return on Capital Employed plunged 13569 bps in 2024, then soared 13039 bps in 2026.
• A 5-year view of Return on Capital Employed shows it stood at 0.4% in 2022, then plunged by 14931 bps to 60.74% in 2023, then plunged by 33 bps to 80.64% in 2024, then jumped by 143 bps to 34.9% in 2025, then grew by 18 bps to 41.13% in 2026.
• The last three Return on Capital Employed figures came in at 41.13% (Q1 2026), 34.9% (Q4 2025), and 85.57% (Q3 2025), per Business Quant data.